FDA Person
FDARanda Melhem
View detailed information about Randa Melhem, including compliance records, violations, and related data.
Person Profile
FDA investigator. Took part in 3 inspections of 3 companies, 2017–2019.
Inspections (3)
| Date | Company | Classification | Project area | Inspection |
|---|---|---|---|---|
| August 2, 2019 | Duke Medical Center-Carolinas Cord Blood Bank and Stem Cell Laboratory | Not classified | #1110495 | |
| November 13, 2018 | GlaxoSmithKline Biologicals | Not classified | #1074672 | |
| April 7, 2017 | Novartis Pharmaceuticals Corporation | Not classified | #1019194 |
Documents (3)
- EIR · Novartis Pharmaceuticals Corporation · April 7, 2017
- 483 · Duke Medical Center-Carolinas Cord Blood Bank and Stem Cell Laboratory · August 2, 2019
- 483 · Baxalta US Incorporated
Person Information
Name
Randa Melhem
Title
investigator
Role
COMPANY REP
ID: 7c1d0c80-f768-487b-83a1-7145b0d0a7f8
Get More Insights
Access our comprehensive quality intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
1.5M+ regulatory data points
Real-time compliance monitoring
Interactive analytics dashboard
Looking for more people? Our platform provides access to thousands of FDA people with advanced search and filtering capabilities.
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.